Aberrant proinflammatory and suppressed anti-inflammatory (alternative; M2) macrophage activation underlies the chronic inflammation associated with obesity and other metabolic disorders. This study demonstrates a critical role for interferon regulatory factor 6 (IRF6) in regulating macrophage M2 activation by suppressing peroxisome proliferator-activated receptor-g (PPARg) expression, a critical regulator of alternative macrophage polarization. The data demonstrate suppression of IRF6 in both M2 macrophages and obese adipose tissue macrophages. Using gainand loss-of-function strategies, we confirmed that IRF6 knockdown enhanced M2 activation, whereas IRF6 overexpression dramatically attenuated M2 activation. Computational target prediction analysis coupled with chromatin immunoprecipitation indicated that IRF6 suppresses PPARg through binding IRF recognition sites located upstream of the PPARg coding region. Taken together, our results suggest that an IRF6/PPARg regulatory axis suppresses anti-inflammatory responses in bone marrow-derived macrophages and provides references for future study addressing dysregulated metabolic and immunologic homeostasis of obese adipose tissue. (Endocrinology 158: 2837(Endocrinology 158: -2847(Endocrinology 158: , 2017 
M acrophages respond to various microenvironmental signals, resulting in a range of activation profiles (1, 2) . Stimulation of macrophages with T helper type 1 cytokines, lipopolysaccharide (LPS), or free fatty acids results in proinflammatory macrophage (classical; M1) activation, whereas T helper 2 cytokines including interleukin (IL)-4 and IL-13 induce anti-inflammatory (alternative; M2) activation (3, 4) . The polarization of tissue-resident macrophages dictates the physiologic or inflammatory state of the tissues they reside in (5, 6) . Adipose tissue macrophages (ATMs) are extremely important for metabolic homeostasis (7) . ATM abundance dramatically increases in obese adipose tissue, and obese ATMs tend to adapt different polarization types than ATMs from lean subjects, which may be a contributing factor of obese-associated chronic inflammation and insulin resistance (7) (8) (9) (10) (11) . Despite their pleiotropic roles, the molecular determinants of macrophage polarization have not been fully elucidated, and this major gap in knowledge is impeding a complete understanding of metabolic disorders (12, 13) .
Interferon regulatory factors (IRFs) are a family of nine transcription factors that primarily regulate immune cell maturation (12) (13) (14) (15) (16) . All IRFs share a homologous N-terminal DNA-binding domain recognizing a consensus DNA sequence, known as the interferon-stimulated response element (ISRE) (17, 18) . Additionally, IRFs transduce signals from pattern recognition receptors and promote expression of various genes, including proinflammatory or anti-inflammatory cytokines (18) . Although several IRFs are required for leukocyte activation and thus important for innate and adaptive immune responses, IRF6, which shares a large degree of structural homology with the proinflammatory IRF5, has not been demonstrated to play a role in immune cells (17, (19) (20) (21) (22) (23) (24) .
To date, knowledge of IRF6 is largely restricted to its role in promoting epithelial cell proliferation and differentiation (25) . IRF6 mutations prevent normal epithelial maturation resulting in the soft tissue fusions characteristic of Van der Woude and popliteal pterygium syndromes in humans (26) (27) (28) . Aside from its function as a morphogenic IRF, epithelial IRF6 also mediates inflammatory toll-like receptor (TLR) signaling through the MyD88 signaling pathway (29) . To our knowledge, it is not known whether a similar role for an IRF6 signaling axis exists in immune cells.
In this study, we demonstrate that IRF6 is crucial for macrophage M2 activation, yet largely dispensable for proinflammatory M1 activation. Furthermore, we demonstrate that IRF6 regulates macrophage polarization by inhibiting the expression of peroxisome proliferator-activated receptor-g (PPARg) through binding two ISREs located upstream of the PPARg genomic region. Our investigation also indicates that IRF6 is dramatically suppressed in ATMs, suggesting that a dysregulated IRF6/PPARg regulatory axis suppresses anti-inflammatory ATM responses and ultimately contributes to dysregulated metabolic and immunologic homeostasis. We propose that IRF6 is a potential therapeutic target for controlling metabolic disorders.
Experimental Procedures

Animal experiments
Wild-type (WT) C57BL/6J mice were used as controls. All mice were maintained on a 12/12-hour light/dark cycle. Male mice 5 to 6 weeks of age were fed ad libitum. Mice were fed a high-fat diet (HFD; 60% fat calories, 20% protein calories, and 20% carbohydrate calories; catalog no. D12492, Research Diets, Inc.) for 16 weeks. A separate group of mice were fed a low-fat diet (10% fat calories, 20% protein calories, and 70% carbohydrate calories; catalog no. D12450J; Research Diets, Inc.) as controls. After the feeding regimen, mice were subjected to phenotype characterization and metabolic assays, including measurement of metabolic parameters in plasma, as well as insulin and glucose tolerance tests. All study protocols used were reviewed and approved by the Institutional Animal Care and Use Committee of Texas A&M University and University of Connecticut Health Center.
Isolation of stromal cells from visceral adipose tissues
The visceral adipose tissues were mechanically dissected and then digested with 2 mg/mL collagenase II (Invitrogen) for 30 minutes at 37°C. After removing red blood cells, cells were filtered through a 200-mm cell strainer. Visceral fat stromal cells (VSCs) and mature adipocytes were separated by centrifugation at 1000g for 5 minutes. To purify ATMs, VSCs were incubated with biotin-labeled antibody against F4/80 (catalog no. 13-4801-85; eBioscience) for identification of macrophages. Magnetic beads conjugated with streptavidin (catalog no. 557812; BD Biosciences) were applied for isolation of macrophages. The efficiency of magnetic bead-based isolation of ATMs was examined with flow cytometry (Supplemental Fig. 1 ).
Macrophage differentiation and polarization
Bone marrow-derived macrophages (BMDMs) were prepared as previously described (30 Quantitative reverse transcription polymerase chain reaction analysis
Total RNA was extracted from ATMs and BMDMs using the TRIzol extraction protocol according to the manufacturer's instructions (Zymo Research). Gene expression analysis was performed using an iScript One-Step RT-PCR kit with SYBR Green (Bio-Rad) on a CFX384 (Bio-Rad). The data presented correspond to the mean of 2 2DDCt from at least three independent experiments after being normalized to b-actin.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assays were performed as described previously (35) . Briefly, BMDMs were cross-linked for 10 minutes with 1% formaldehyde and quenched with 125 mM glycine. After nuclei were isolated by centrifugation, the pellet was resuspended in lysis buffer containing 0.1% sodium dodecyl sulfate and sonicated to achieve fragment sizes of 200-600 bp. The immunoprecipitation was conducted with ChIP-grade protein G magnetic beads using an antibody against IRF6 (catalog no. NBP1-51911; Novus Biologicals). Immunoglobulin G (IgG) protein (catalog no. ab18413; Abcam) was used as the negative control ( Table 2 ). To validate the enrichment, quantitative polymerase chain reaction (PCR) was performed with tiled primers.
Luciferase reporter assay
The luciferase reporter assay was carried out as described previously (18) . To verify that IRF6 binds to the upstream region of PPARg, a 478-bp DNA fragment (21857 to 21379 relative to the 5 0 end) within the upstream region of PPARg was inserted upstream of the SV40 promoter of the pGL3 promoter vector (Promega). Constructs with mutated binding sites were generated using the QuikChange Site-Directed Mutagenesis Kit (catalog no. 200518-5; Stratagene) followed by sequencing validation (Table 3 ). The luciferase activity was determined by transient transfection HEK-293 cells (CRL-1573; American Type Culture Collection) with Bright-Glo luciferase reporter system (Promega) and normalized to the control firefly luciferase activity.
Lentiviral short hairpin RNA assay
The pLKO.1-CMV-TurboGFP TM vector (Sigma-Aldrich) with inserted short hairpin RNA (shRNA; targeting IRF6) was cotransfected with compatible packaging plasmids into HEK-293 cells. The lentiviral supernatants were collected after 72 hours transfection and used to infect BMDMs. The empty vector was used as the control.
Ectopic expression assays
To overexpress IRF6, the open reading frame sequence was inserted downstream of the cytomegalovirus promoter in the XZ201 plasmid. These constructs were delivered into target cells by transient transfection with X-tremeGENE HP DNA transfection reagent (Roche Applied Science). The empty vectors were used as the control. The overexpression was validated by reverse transcription PCR (RT-PCR).
Statistics
Results are expressed as means 6 standard error of the mean (SEM). Each data point derived from RT-PCR assays represents an average of two technical replicates, and data were averaged over independently replicated experiments (n = 5 to 6 independently collected samples) and analyzed using the Student t test. The overall effect was analyzed for significance using one-way or two-way analysis of variance and the Bonferroni posttest for each factor at each individual time when appropriate. Data analyses were performed using Prism version 6.0 software (GraphPad). A value of P , 0.05 was considered statistically significant.
Results
Obese ATMs present decreased M2 ATM population ATMs were isolated from C57BL/6J mice fed an HFD from 5 weeks of age for 16 weeks [ Fig. 1(a) ].
ATMs derived from obese mice exhibited significantly higher proportion of M1 (F4/80 IRF6 is significantly reduced in obese ATMs and M2-polarized macrophages To determine if IRF6 played a role in mediating the altered profile of macrophage activation in obese mice, we examined its expression in response to M1 and M2 macrophage polarization. Compared with M1 BMDMs, M2 BMDMs presented significantly higher CD206 surface expression (Supplemental Fig. 2) . Interestingly, IRF6 levels significantly decreased upon M2 polarization while remaining unchanged upon LPS-induced M1 polarization [ Fig. 2(a) ]. Further analysis revealed the dramatically decreased IRF6 expression in M2 macrophages beginning as early as 5 hours poststimulation, which persisted for at least 72 hours [ Fig. 2(b) ]. Thus, IRF6 expression is suppressed in M2 macrophages, whereas IRF6 levels in M1 macrophages were unaffected. We also profiled the expression of IRF6 in ATMs isolated from lean and obese mice. Unexpectedly, it was found that IRF6 was dramatically reduced in ATMs from obese mice compared with ATMs from lean mice [ Fig. 2(c) ].
IRF6 negatively regulates M2 macrophage polarization
We tested if the differential expression of IRF6 observed in M2 macrophages was necessary for polarization by using gain-and loss-of-function strategies. First, BMDMs were transduced with an IRF6 overexpression construct (IRF6oe BMDMs) and subsequently stimulated with IL-4 [ Fig. 3(a) ]. Flow cytometric analysis revealed overexpression of IRF6 blunted M2 activation, with a considerable reduction of activation-related surface markers, CD69 and CD86, in IRF6oe BMDMs after 48 hours of stimulation [ Fig. 3(b) ]. Subsequent gene expression analysis also confirmed reduced levels of M2 signature genes, including PPARg, Arg1, and IL-10, in . Asterisks indicate significant differences from lean mice: *P , 0.05; **P , 0.01; ****P , 0.0001.
IRF6oe BMDMs [ Fig. 4(a) ]. However, PGC1a and PGC1b expression remained unchanged, suggesting that the reduced levels of M2 markers were not due to a cytotoxicity-induced global reduction in gene expression. Although IRF6 expression remained unchanged in M1-polarized BMDMs, we reasoned that IRF6 might modulate M1 activation given its shared homology with IRF5 (23, 24) . However, BMDMs with ectopic IRF6 expression that were stimulated with LPS did not exhibit differences in activation, as shown by unchanged CD69 and CD86 surface marker expression [ Fig. 3(c) and 3(d) ]. Additionally, IRF6oe BMDMs stimulated with LPS showed no differences in expression of proinflammatory cytokines tumor necrosis factor and IL-1b [ Fig. 4(b) ].
Loss-of-function experiments were conducted using BMDMs transduced with an IRF6 shRNA construct Fig. 6(b) ]. Taken together, our results suggest that although IRF6 plays a central role in suppressing M2 polarization, it does not appear to influence M1 activation.
IRF6 suppresses M2 polarization by directly binding to the PPARg promoter and inhibiting its expression
Given the central role PPARg has in promoting M2 polarization, we surveyed the upstream region of PPARg for ISREs (33, (39) (40) (41) . Using both the JASPAR database (http://jaspar.binf.ku.dk/) and previously reported IRF6 consensus binding sequences, we predicted five potential IRF6 binding sites within 4 kb upstream of the PPARg coding region [ Fig. 7(a)] (42, 43) . To identify genuine IRF6 binding sites, we performed ChIP on M2-polarized BMDM nuclear fractions with antibodies directed against IRF6. The enrichment of ISREs was examined by quantitative PCR with primer pairs flanking each predicted ISRE. Interestingly, two ISREs (ISRE1: 21444 to 21438, and ISRE2: 21782 to 21776; both having the sequence 5 0 -GAAACT-3 0 , relative to the 5 0 end of the PPARg coding region) displayed substantial enrichment, as evidenced by the fold change relative to total DNA input and IgG control [ Fig. 7(b) ].
To validate the role of these two ISREs in mediating IRF6-regulated transcription, the genomic sequence harboring both ISREs (21857 to 21379, relative to the 5 0 end of PPARg coding region) was inserted upstream of a luciferase reporter [pGL3-IRF6-WT; Fig. 7(c) ]. To further define the binding efficiency of ISREs, we generated mutant constructs bearing mutations at 21782 (pGL3-IRF6-Mut1), 21444 (pGL3-IRF6-Mut2), or both (pGL3-IRF6-Mut1/2) ( Table 1) . Luciferase activity was examined in cells activated for induction of PPARg. Our results demonstrate that promoter constructs containing identified ISREs with enriched binding efficacy for IRF6 displayed suppressed luciferase activity compared with cells transfected with control vector [ Fig. 7(d) ]. Interestingly, mutation of ISRE-1782 (Mut1) but not ISRE-1444 (Mut2) partially rescued suppression in activated cells, whereas double mutation (pGL3-IRF6-Mut1/2) displayed slightly higher luciferase activity than mutation of ISRE-1782 (Mut1). Taken together, these results demonstrate that IRF6 represses PPARg expression in macrophages primarily through binding to ISRE-1782 located upstream of the PPARg coding region.
Discussion
Macrophage polarization is a tightly regulated process controlled by well-orchestrated gene transcriptional networks resulting from microenvironmental stimuli (44, 45) . Dynamic expression of the IRF family of transcription factors is known to be crucial for immune cell activation through their interaction with pattern recognition receptor-associated signaling pathways (46, 47) . Previous studies indicate that several IRF family members, including IRF1, IRF5, and IRF7, interact with MyD88 to trigger the TLR-mediated expression of proinflammatory genes, and other IRFs have anti-inflammatory properties. IRF4 acts downstream of the IL-4 receptor/signal transducer and activator of transcription (STAT) 6 signaling cascade to attenuate TLR-dependent inflammatory responses by competing with IRF5 for binding to MyD88 (18, 19, 48) .
Similar to IRF4, our study indicates that IRF6, a poorly characterized IRF family member, acts downstream of the IL-4 signaling pathway to influence M2 macrophage activation. Indeed, we observed that IRF6 expression was repressed during the initial stages of M2 activation, but remained unresponsive to LPS stimulation. In contrast to IRF4, our results indicate IRF6 acts as a physiologic "brake" for M2 macrophage responses until encountering appropriate environmental cues. Furthermore, we demonstrated that IRF6 regulates alternative macrophage polarization through a regulatory mechanism independent from the interactions with TLR/MyD88 signaling that characterize other IRF family members. One potential molecular explanation for IL-4's impact on IRF6-mediated M2 polarization is the presence of 10 STAT consensus sites upstream of IRF6, as determined by the JASPAR prediction algorithm, suggesting STAT6 might suppress IRF6, but this remains to be determined. Until this study, the relationship between IRFs and PPARg-dependent alternative macrophage activation was unclear. PPARg is a crucial regulator of alternative macrophage polarization because it is known that PPARg-deficient macrophages exhibit impaired M2 macrophage responses (39, 49) . Our findings reveal that IRF6 directly represses PPARg expression through direct binding to ISREs located upstream the PPARg coding region, primarily ISRE-1782, and that IL-4-induced downregulation of IRF6 expression licenses PPARgdependent alternative M2 activation. Our study contrasts with previous work that did not find a role for IRF6 in macrophage activation (29, 50 ). However, a major difference is that those studies were directed to characterization of IRF6 expression in circulating human monocytes.
The balance between alternative and proinflammatory macrophage activation is particularly relevant to the pathogenesis of chronic adipose tissue inflammation in obesity. Obese adipose tissue is characterized by massive expansion of resident ATMs that manifest proinflammatory responses by suppressing anti-inflammatory pathways (8, 9) . Prior research demonstrated that macrophage-specific PPARg deficiency attenuates alternative ATM polarization and exacerbates obesityassociated insulin resistance (39, 51, 52) . Our findings suggest that a dysregulated IRF6/PPARg regulatory axis in BMDMs and might provide references for future study addressing suppressed anti-inflammatory ATM responses. In our study, the IRF6 expression was lower in obese ATMs than in lean ATMs, despite the latter containing a higher portion of M2 macrophages. Unpolarized BMDMs presented rapid decrease in IRF6 levels upon M2 activation, suggesting involvement of IRF6 in the initial steps of M2 polarization. In contrast, the obese/lean ATMs were isolated from mice after 16 weeks feeding with low-fat diet/ HFD and thus may contain well-established macrophage populations of different polarization types. The difference in IRF6 levels in BMDMs and ATMs suggest that this molecule may play different roles in triggering and maintaining of the macrophage polarization. In addition, it should be noted that ATMs in vivo may adapt numbers of polarization types besides the typical M1/M2 activation (7-11, 53, 54) , and further studies are needed to validate the IRF6-PPARg axis in animal models and human tissues at different stages of macrophage differentiation. Given the role of adipocyte-intrinsic PPARg in mediating insulin sensitivity, it would be important to probe whether a similar interaction between IRF6 and PPARg is present within adipocytes and might thus contribute to metabolic dysfunction in obesity (55) (56) (57) . Further analysis of IRF6 will provide crucial information to understand macrophage action and might suggest gene targets for drug development to mitigate metabolic and inflammatory-based diseases.
